Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06027580 · ClinicalTrials.gov registry record
Orthosis to Improve Trunk Control in Infants Age 6-18 Months
A clinical trial of Cerebral Palsy, sponsored by Medical College of Wisconsin.
- Recruiting
- Registry status
- 30
- Enrollment target
- 1
- Study location
NCT06027580: Recruiting study of Cerebral Palsy, sponsored by Medical College of Wisconsin.
NCT06027580 is a study of Cerebral Palsy that is actively recruiting participants, run by Medical College of Wisconsin. The registered enrollment target is 30 participants, below the 229-participant average among 91 other Cerebral Palsy trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06027580, a study of Cerebral Palsy, is actively recruiting participants, sponsored by Medical College of Wisconsin.
- RECRUITING
- Registry status
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine the impact of the SPIO® Core-MAX® Expedition orthosis on an infant's head, trunk and upper limb function.
Primary Outcome
Degree change in head and trunk position from centerline as assessed by motion capture.
Conditions Studied
Interventions
- DEVICE SPIO® Core-MAX® Expedition thoracolumbosacral orthosis
- OTHER Standard Care Therapy option
Study Locations (1)
Wisconsin
- Medical College of Wisconsin/Children's Wisconsin - Milwaukee
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2024-02-21 |
| Est. Completion | 2026-08-06 |
What NCT06027580 shows while recruiting
NCT06027580 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 229-participant average among 91 other Cerebral Palsy trials with a reported enrollment target (87% lower).
The record links to 1 condition, with Cerebral Palsy appearing as the primary indexed condition, and to 2 interventions - of which SPIO® Core-MAX® Expedition thoracolumbosacral orthosis is the first listed.
NCT06027580 reports a single indexed study location in Wisconsin.
Frequently Asked Questions
What is clinical trial NCT06027580 about?
NCT06027580 is a clinical study titled "Orthosis to Improve Trunk Control in Infants Age 6-18 Months". The purpose of this study is to determine the impact of the SPIO® Core-MAX® Expedition orthosis on an infant's head, trunk and upper limb function.
What is the current status of trial NCT06027580?
This trial is currently recruiting. The enrollment target is 30 participants. The study started on 2024-02-21. Estimated completion is 2026-08-06.
What conditions does trial NCT06027580 study?
This clinical trial studies the following conditions: Cerebral Palsy.
What interventions are being tested in trial NCT06027580?
The interventions under investigation include: SPIO® Core-MAX® Expedition thoracolumbosacral orthosis (DEVICE), Standard Care Therapy option (OTHER).
Who is sponsoring clinical trial NCT06027580?
This trial is sponsored by Medical College of Wisconsin, which has 447 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06027580 being conducted?
This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cerebral Palsy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06027580's enrollment target sits among peer trials
30 55th of 91 higher than 29 of 91 other Cerebral Palsy trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cerebral Palsy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Stand-on Ride-on Power Mobility Devices for Children With Cerebral Palsy
RECRUITING · Early Phase 1
-
Motor Training for Infants With Cerebral Palsy
RECRUITING · NA
-
Implementation of Therapy Together
RECRUITING · NA
-
Evaluating Long-term Use of a Pediatric Robotic Exoskeleton (P.REX/Agilik) to Improve Gait in Children With Movement Disorders
RECRUITING · NA
-
Em-power: Maximizing Functional Independence for Children With Severe Cerebral Palsy
RECRUITING · NA
-
Evaluation of Brain MRI Changes in Cerebral Palsy Patients
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI